Lumbar radiculopathy — USMLE Step 3 MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Start a direct-acting oral anticoagulant independent of the CHA2DS2-VASc score
The best answer is “Start a direct-acting oral anticoagulant independent of the CHA2DS2-VASc score”. Hypertrophic cardiomyopathy confers substantial thromboembolic risk with clinical AF, so anticoagulation is recommended independent of CHA₂DS₂-VASc. A DOAC is generally preferred unless a contraindication exists. Aspirin or waiting for recurrent/prolonged AF leaves avoidable stroke risk.
Reference: 2024 AHA/ACC Guideline for the Management of Hypertrophic Cardiomyopathy: https://professional.heart.org/en/science-news/2024-guideline-for-the-management-of-hypertrophic-cardiomyopathy